Skip to content

INSTAPHARMA

Active Private limited company (pre-2019)founded 2007active for 18 yearsAbdijstraat 115, 2020 AntwerpKBO/BCE: BE 0893.761.760 subsidiary of

Lifetime

18 annual accounts with figures on one time axis
peak of €748,463 in 2025
€748,463▲ 42.2%
lowest -€382,984 in 2011
€155,893▲ 17×
peak of €219,782 in 2025
€219,782▲ 19.5%
€1.9m▼ 18.5%
peak of 10 FTE in 2019
4.6 FTE▲ 21.1%
Board1 name since 2012
1 director
Owners
100%
Documentsfilings and deeds
30-07-20261 day before the deadline
2025abbreviated format
Gross margin from €526,169 to €748,463Result from €9,292 to €155,893Staff from 3.8 FTE to 4.6 FTEEquity from €183,889 to €219,782Debts from €2.3m to €1.9m

Key points

from the 2025 annual accounts

Equity

€219,782 ▲ 19.5%

INSTAPHARMA has made a profit without a break since 2021.

Result

€155,893 ▲ 17×
€9,2902024€156,0002025

The result rose in 2025 from €9,292 to €155,893.

Debts

€1.9m 90% of the balance sheet
Financial debts 59%Suppliers 25%Taxes and wages 2%Other 14%

Of this, €817,111 falls due within a year.

Investments

€30,557 0.2 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Staff

4.6 FTE from 10 in 2019

Between 2019 and 2025, the number of full-time equivalents fell by 54%.

Filings

18 annual accounts since 2008
AprilJune31 JulyOctober2010201520202025

Eight of the last ten came late. The 2019 accounts came in latest, 129 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 5,052 companies had the same profile as INSTAPHARMA has now. Each dot stands for 13 companies, two years later.

95.9%
were still trading
2.4%
stopped another way
1.6%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 5,052 companies, not a prediction for INSTAPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager, , since 01-02-2012
  • 100%score equity €612,382 (2025) · annual accounts 2025 of
  • annual accounts 2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0893761760
Registered office moved within Antwerp The registered office moved from Kanunnikenstraat 15, 2020 Antwerpen to Abdijstraat 115, 2020 Antwerpen · acts as permanent representative · Board meeting of 12-05-2017 · Gazette deed
Company renamed from FARMACORT to Instapharma General meeting of 16-08-2013 · Gazette deed
New manager appointed, resigned · and act as permanent representatives · General meeting of 31-01-2012 · Gazette deed
All 34 events

Comparable companies

same main activity, similar in size and age
Company
INSTAPHARMA Antwerp €2.1m €748,463 10.3% 4.6
APOTHEEK DEMEULENAERE Retie €2.6m €774,970 45.6% 5.1
MANAGEMENT MEYERS-CASTEELE Landen €2.5m €736,145 78.8% 4.4
APOTHEEK VERZELE-HAEMS Ghent €2.2m €599,218 39.3% 4.4
OPNIPHAR Buggenhout €1.9m €627,366 28.1% 5.5
BRAECKEVELT-LAFAUT Bruges €2.4m €584,272 19.3% 4.2
J.M.C. Remicourt €2.0m €665,034 80.9% 3.9

These companies have the same main activity as INSTAPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.9m and €2.6m, founded between 2003 and 2010.

Official details

Source: KBO
Status
Active since 27-11-2007Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 1 other
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment units
2.167.319.2032020 Antwerp, since 01-01-2008
2.167.319.3022650 Edegem, since 01-01-2008
Financial year end
31 December
Peppol
Reachable since 17-06-2025
Company details

Annual accounts 2025

≈ €2.6mestimated
€2.1m▼ 15.8%
Employeeson 31-12-2025
7▲ 40.0%
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on INSTAPHARMA

INSTAPHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €634,914 in 2008 to €748,463 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about INSTAPHARMA

What is the company number of INSTAPHARMA?
The company number of INSTAPHARMA is 0893.761.760. The VAT number is the same number with BE in front: BE 0893.761.760.
Where is INSTAPHARMA based?
The registered office is at Abdijstraat 115, 2020 Antwerp.Company details
What does INSTAPHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of INSTAPHARMA?
INSTAPHARMA is a private limited company (pre-2019) (BVBA).
When was INSTAPHARMA founded?
INSTAPHARMA was founded on 27-11-2007.
Is INSTAPHARMA still active?
Yes, INSTAPHARMA is an active enterprise in the KBO register.
How many employees does INSTAPHARMA have?
INSTAPHARMA had an average of 4.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does INSTAPHARMA fall under?
In its 2025 annual accounts, INSTAPHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of INSTAPHARMA?
The turnover in financial year 2025 is about €2.6m. This figure is estimated from the gross margin of €748,463 and 42 comparable companies (NACE 477). It probably lies between €2.0m and €3.6m.
Is INSTAPHARMA profitable?
In financial year 2025, INSTAPHARMA made a profit of €155,893.
Where can I find the annual accounts of INSTAPHARMA?
INSTAPHARMA filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of INSTAPHARMA due?
INSTAPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.